247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

Mankind Pharma Limited IPO (Mankind Pharma IPO) Details

Mankind Pharma Limited is an Pharmaceutical based company, located in New Delhi, Mankind Pharma Limited IPO size was 4326.36 Cr. and was issued at 1080.00 per share. The share of Mankind Pharma Limited were listed at 1424.05 per share and are currently trading at 2704.70 per share.

Type :
Sub Sector : Pharmaceutical Products With A Major Focus On Domestic Markets
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
9037.09 Cr.

PAT :
1346.92 Cr.

Pricing Report

Issue Price :
1080.00

Listing Price :
1424.05

Current Market Price :
2704.70

Issue Price vs CMP :
1624.7 (150.44%)

listing Price vs CMP :
1280.65 (89.93%)

Performance Report (CAGR* wise)

CAGR : 71.23
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Mankind Pharma

Company Information
Mankind Pharma Limited is India
Object of Issue
  • The company will not receive any proceeds from the offer and all the offer proceeds will be received by the selling shareholders, in proportion to the offered shares sold by the respective selling shareholders as part of the offer

Mankind Pharma MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
May, 2023
IPO Size :
4326.36 Cr.
Market Cap :
43263.60 Cr.   
IPO Subscription :
15.32 X     
PE Multiple :
0.00
Merchant Banker :
Axis Capital Limited
IPO Registrar:
Kfin Technologies Limited

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other MainBoard IPOs in New Delhi


ACME Solar Holdings Limited

  renewable energy projects and power generation.

  New Delhi


Action Construction Equipment Limited

  construction equipments manufacturing

  New Delhi


Peer Companies Of This Sector

FAQs

Mankind Pharma operates in Pharmaceutical and Pharmaceutical Products With A Major Focus On Domestic Markets. The Issue is listed on MainBoard in May, 2023. Mankind Pharma IPO size was 4326.36 Cr. with Issue price of 1080.00 .

Merchant Banker(s) of Mankind Pharma IPO: Axis Capital Limited , Iifl Securities Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited

Mankind Pharma IPO subscription was 15.32 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Mankind Pharma IPO listed at a listing price of 1424.05 against the offer price of 1080.00.

The current market price of Mankind Pharma is 2704.70.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency